These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27923648)

  • 1. Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: An immunohistochemical study.
    Hansel K; Bellini V; Bianchi L; Brozzi J; Stingeni L
    J Allergy Clin Immunol Pract; 2017; 5(3):808-810. PubMed ID: 27923648
    [No Abstract]   [Full Text] [Related]  

  • 2. An unusual case of delayed-type hypersensitivity to ceftriaxone and meropenem.
    Dias de Castro E; Leblanc A; Sarmento A; Cernadas JR
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):225-7. PubMed ID: 26549341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRESS Syndrome due to benzylpenicillin with cross-reactivity to amoxicillin.
    Watts TJ; Li PH; Haque R
    J Allergy Clin Immunol Pract; 2018; 6(5):1766-1768. PubMed ID: 29408014
    [No Abstract]   [Full Text] [Related]  

  • 4. DRESS Syndrome Induced by Ranitidine.
    Watts TJ; Haque R
    J Allergy Clin Immunol Pract; 2018; 6(3):1030-1031. PubMed ID: 29102410
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative rash to ceftriaxone.
    San Miguel MM; Gaig P; Bartra J; García-Ortega P
    Allergy; 2000 Oct; 55(10):977-9. PubMed ID: 11030384
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-reactivity of cephalosporins: allergic immediate hypersensitivity to ceftriaxone in a cefcapene pivoxil-sensitized patient.
    Deguchi T; Shimomura Y; Hayashi R; Orime M; Tomiyama K; Abe R
    Eur J Dermatol; 2017 Apr; 27(2):187-189. PubMed ID: 27934618
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test.
    Padial A; Antunez C; Blanca-Lopez N; Fernandez TD; Cornejo-Garcia JA; Mayorga C; Torres MJ; Blanca M
    Clin Exp Allergy; 2008 May; 38(5):822-8. PubMed ID: 18331363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teicoplanin-induced immediate and delayed hypersensitivity reactions.
    Harper V; Nasser SM
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):223-226. PubMed ID: 32416230
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed Cutaneous Hypersensitivity Reactions to Antibiotics: Management with Desensitization.
    McNulty CMG; Park MA
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):751-760. PubMed ID: 28965638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral challenge without skin testing in children with suspected non-severe betalactam hypersensitivity.
    Pouessel G; Winter N; Lejeune S; Thumerelle C; Deschildre A
    Pediatr Allergy Immunol; 2019 Jun; 30(4):488-490. PubMed ID: 30817036
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal Anaphylactic Shock Ceftriaxone-Induced in a 4-Year-Old Child.
    Calapai G; Imbesi S; Ventura-Spagnolo E; Cafeo V; Milone L; Navarra M; Gangemi S
    Pediatr Emerg Care; 2016 Jan; 32(1):32-3. PubMed ID: 25513979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS Syndrome).
    Holbrook MB; Glick J
    J Emerg Med; 2019 May; 56(5):562-563. PubMed ID: 30879852
    [No Abstract]   [Full Text] [Related]  

  • 14. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed Drug Eruption Related to Cefixime in an Adolescent Case.
    Kulhas Celik İ; Buyuktiryaki B; Misirlioglu ED; Hasbek E; Kocabas CN
    J Allergy Clin Immunol Pract; 2018; 6(5):1742-1743. PubMed ID: 29339130
    [No Abstract]   [Full Text] [Related]  

  • 16. [DRESS syndrome in paediatrics: Clinical case].
    Silva-Feistner M; Ortiz E; Rojas-Lechuga MJ; Muñoz D
    Rev Chil Pediatr; 2017 Feb; 88(1):158-163. PubMed ID: 28288233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug.
    Bensaid B; Rozieres A; Nosbaum A; Nicolas JF; Berard F
    J Allergy Clin Immunol; 2012 Dec; 130(6):1413-4. PubMed ID: 22840850
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug reaction with eosinophilia and systemic symptoms and cytomegalovirus colitis.
    Krummenacher M; Banovic T; Kette F; Smith W; Hissaria P
    Ann Allergy Asthma Immunol; 2019 Oct; 123(4):401-403. PubMed ID: 31376489
    [No Abstract]   [Full Text] [Related]  

  • 19. Case of drug reaction with eosinophilia and systemic symptoms secondary to vancomycin.
    Chamorro-Pareja N; Patel A; Youngberg G; Gonzalez-Estrada A
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30301733
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane.
    Le TM; Sanders CJ; van de Corput L; van Erpecum KJ; Röckmann H
    J Allergy Clin Immunol Pract; 2016; 4(1):175-6. PubMed ID: 26298826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.